There are 413 resources available
144P - TRIple-Negative Breast Cancer PrOspective Registry in MiddLe East AfrIca (TRIPOLI) Study: Interim Analysis of treatment outcomes in patients who received neoadjuvant therapy
Presenter: Hamdy Azim
Session: Poster viewing and lunch
145P - Pathological complete response in young women with breast cancer in connection with pathogenic germline BRCA1 variants and subtype
Presenter: Anna Hage
Session: Poster viewing and lunch
146P - Updated survival analysis in NEOPERSUR trial: Neoadjuvant Pertuzumab in a real-world population in the south of Spain.
Presenter: Alejandro Falcon Gonzalez
Session: Poster viewing and lunch
147P - Germline BRCA Mutation Status and Response to Neoadjuvant Systemic Therapy in Breast Cancer.
Presenter: Hyunyou Kim
Session: Poster viewing and lunch
148P - Pattern of axillary lymph node involvement and scope of post neoadjuvant chemotherapy sentinel lymph node biopsy among breast cancer patients in developing countries.
Presenter: ASHUTOSH MISHRA
Session: Poster viewing and lunch
149P - HER2-low status and response to neoadjuvant chemotherapy in early breast cancer
Presenter: Gulin Alkan
Session: Poster viewing and lunch
150P - Pathological complete response after neoadjuvant chemotherapy in Her2 positive breast cancer, efficacy of biosimilar compared to Herceptin®
Presenter: Nassima Kouadri
Session: Poster viewing and lunch
151TiP - Study in progress - Pre-Operative Oncotype DX® testing: A decision impact study (PRE-DX)
Presenter: Grant Harris
Session: Poster viewing and lunch
152TiP - Trial in progress: Imatinib to convert triple negative breast cancer into estrogen receptor (ER) positive breast cancer - a window of opportunity trial
Presenter: Barbro Linderholm
Session: Poster viewing and lunch
153TiP - Effects Of Resistance vs. Aerobic Training On Ki-67 And Other Health-Related Biomarkers: The Neo-Program, A Randomized Controlled Trial On Breast Cancer Patients Undergoing Neoadjuvant Treatment
Presenter: Joana Ribeiro
Session: Poster viewing and lunch